We now see DDD moving more aggressively into implants that can only be made right via EBM... they will try to circumvent Arcam's corner on this market... that will result in patent battles... we will see...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.